Chapter 31: Disorders of Ventilation and Gas Exchange
Welcome to Last Minute Lecture.
This free chapter overview is designed to help students review and understand key concepts.
These summaries supplement not replaced the original textbook and may not be redistributed or resold.
For complete coverage, always consult the official text.
Welcome to the Deep Dive.
Today, we're tackling something absolutely fundamental to health, how the lungs fail.
We're going straight into the path of physiology, really digging into ventilation and gas exchange disorders.
Yeah, it's crucial stuff, because at its heart, the lungs job seems simple, right?
Get oxygen in, get carbon dioxide out,
O2 for CO2.
Simple concept, but.
But it depends on so much working perfectly.
You need open airways, the lungs have to actually expand, you need enough surface area for that gas swap, and critically enough blood flow perfusion to carry it all away.
Any break in that chain?
Well, that's where disease starts.
Okay, so we've mapped out five key areas to unpack for you today.
First, the direct consequences, hypoxemia and hypercapnia.
What happens when the gas levels go wrong?
Then we'll look at the mechanics problems with lung inflation itself.
After that, the flow issues, you know, the obstructive diseases.
Like asthma and COPD.
Exactly.
Then the opposite problem, kind of restrictive diseases where the lungs get stiff.
And finally, we'll hit the big acute problems involving blood vessels and overall lung failure.
Sounds like a good plan.
Let's dive in.
All right.
Segment one, hypoxemia and hypercapnia.
These are the two big chemical failures, right?
Often talked about together, but distinct causes.
Absolutely distinct.
Hypoxemia is low oxygen in the arterial blood, technically, a PAO2 less than 95 millimeters of mercury.
Hypercapnia is high carbon dioxide, high PCO2.
Okay.
And here's the key difference, you know.
Hypoxemia really hinges on diffusion.
Can oxygen actually get across that tiny membrane between the air sac and the blood vessel?
Right.
The alveolar capillary membrane.
Precisely.
Hypercapnia, though, is mostly about minute ventilation.
How much air are you actually moving in and out each minute?
If you can't blow off that CO2, it builds up.
Simple as that, fundamentally.
And underlying both very often is this concept of VQ matching, ventilation profusion matching.
The cornerstone, really.
You need air, ventilation, V, and blood profusion Q to meet at the same place at the same time.
Normally it's about a one -to -one ratio.
So what happens when it's not one -to -one, like a low VQ?
That's what we call a shunt.
Think of it like blood flowing past an air sac, but the air sac is full of gunk, maybe fluid from pneumonia or pus.
So profusion without ventilation.
Yeah.
Blood goes by, no oxygen pickup.
Exactly.
The blood just bypasses the oxygenation step.
Now, the opposite is a high VQ ratio, or dead space.
Air, but no blood.
Right.
The air sacs are full of lovely fresh air, but maybe a blood clot, a pulmonary embolus, is blocking the blood flow to that area.
So ventilation without profusion.
The air is there, but it can't get into the bloodstream.
And the worst case?
The silent unit.
No air, no blood flow.
You see that in really severe conditions, like ARDS, acute respiratory distress syndrome, just complete failure of that lung unit.
Okay.
Let's focus on hypoxemia first.
Low oxygen.
What does the body do immediately?
Which parts feel it first?
Well, the big oxygen hogs suffer first, the brain, the heart, the lungs themselves.
Initially, your sympathetic nervous system kicks in hard, heart rate jumps up, blood vessels in the periphery clamp down.
Trying to prioritize the core.
Right.
But as that oxygen level keeps dropping, the central nervous system effects become really obvious.
Confusion, weird personality changes, sometimes even euphoria, which is dangerous.
Judgment gets severely impaired.
And if it goes on long enough?
If it's really severe, the body's forced into anaerobic metabolism.
No oxygen for the usual energy pathways.
That cranks out lactic acid, leading to metabolic acidosis.
What about people living with chronic low oxygen?
They adapt, sort of.
They do adapt, though it's not ideal.
Ventilation often increases.
You get this weird pulmonary vasoconstriction.
The lung vessels clamp down in low oxygen areas, trying to redirect blood.
And importantly, the kidneys release erythropoietin, stimulating red blood cell production.
That's polysithemia.
Trying to carry more oxygen with more carriers.
Exactly.
More trucks on the road, even if they aren't fully loaded.
You might also see cyanosis, that bluish tinge.
But cyanosis is late, isn't it?
Oh, very late.
You need a significant amount of hemoglobin, about five grams per deciliter, to be deoxygenated before you see it clearly.
And a really important point from the source material.
For assessing people with darker skin, you have to look at the mucous membranes, like inside the mouth, the buccal tissue.
Skin changes might not be obvious.
Good tip.
Okay.
Diagnosing.
Arterial blood gases, ADGs, they're the gold standard.
Definitely.
Gives you the actual partial pressures of O2 and CO2, the pH, everything.
But we use pulse oximeters all the time.
Non -invasive.
What's the catch there?
They're great for trending saturation, but they have limits.
Big ones.
They just measure how saturated the hemoglobin is, not the actual amount of oxygen dissolved, the PO2.
And crucially, they can't tell the difference between hemoglobin carrying oxygen and hemoglobin carrying, say,
carbon monoxide.
Ah, so in CO poisoning, the reading could look falsely good.
Exactly.
Or with methamaglobinemia.
So useful, but you need to be aware of the pitfalls.
For tracking the severity of the diffusion problem, the PF ratio is really helpful.
PO2 divided by FIO2.
Right.
Arterial O2 pressure divided by the fraction of inspired oxygen you're giving the patient.
Normally, it's way above 300.
If that number starts plummeting, you know the diffusion barrier itself is failing badly.
Okay.
Let's flip to the other side.
Hypercaptia.
Too much CO2.
Immediate effect.
Acidosis.
Grace.
Respiratory acidosis.
The CO2 dissolves in the blood, forms carbonic acid, drops the pH fast, and high CO2 itself is a narcotic to the brain.
CO2 narcosis.
Makes people sleepy, confused.
Progressively somnolent, yeah.
Before that, though, you usually see signs of increased work of breathing.
The body's struggling to blow off that CO2.
So shortness of breath, fast breathing to chipnia, and often that classic purslet breathing you see in COPD patients.
Trying to keep airways open longer on exhale.
That's the idea.
Creates a bit of back pressure.
All right.
Let's move to segment two.
Problems with lung inflation.
The actual mechanics failing.
Ombud involves the pleura, that space around the lungs.
Exactly.
That pleural space normally has negative pressure, kind of sucking the lung outward against the chest wall.
If that space fills up with stuff, it shouldn't come at fluid, blood, air.
The lung gets squashed or collapses.
Starting with fluid.
Plural effusion.
Different kinds of fluid tell different stories.
They do.
You've got transudate, which is usually clear, watery fluid.
Low protein.
Think conditions that increase pressure in the capillaries, like congestive heart failure or decreased protein in the blood.
It's more of a passive leakage.
Hydrothorax is another name for it.
Okay.
And the other type.
Exudate.
This is inflammatory fluid.
Thicker, higher in protein, higher in LDH, lactate dehydrogenase.
It means there's inflammation or infection involving the pleura itself.
If that exudate is frank pus.
Empiema.
Empiema.
Usually related to pneumonia nearby, a peritoneumonic effusion that's become infected.
And if it's not fluid or pus, but blood.
Hyrothorax.
Hyrothorax is serious business, especially if it's moderate or large.
Two problems.
The blood compresses the lung, obviously, but you're also losing blood volume from your circulation.
Fast.
So drain the chest, replace the volume.
Urgently.
Absolutely.
And if it's not drained properly, that blood can clot and organize, forming fixed tissue called fibrothorax that can permanently trap the lung, restricting its movement.
Nasty.
Okay.
The third thing that can fill that space.
Air.
Pneumothorax.
Simple collapse versus tension pneumothorax.
What makes tension so deadly?
It's the mechanism.
A simple pneumothorax means air got in, the lung collapses.
End of story for now.
But a tension pneumothorax acts like a one -way valve.
Air gets into the pleural space when the person breathes in, but it can't get out when they breathe out.
So pressure just builds and builds.
Relentlessly.
It completely collapses the lung on that side.
And then the pressure gets so high, it starts pushing everything in the middle of the chest.
The heart, the big blood vessels, the trachea over to the opposite side.
That's the mediastinal shift you hear about.
That's it.
And the killer is that shift kinks or compresses the vena cava, the big vein returning blood to the heart.
Blood can't get back to the heart.
So cardiac output clemets.
You get shock, circulatory collapse.
It's fatal very quickly if you don't decompress it immediately.
And you might see the trachea physically shifted to one side.
Classic sign.
A surgical emergency.
Okay.
One more inflation problem.
Adellectasis.
Lung collapse or incomplete expansion, usually acquired.
It can be from obstruction or compression, but there's a key diagnostic clue about which way things shift.
Yes.
And it seems counterintuitive, but it's crucial.
If the adellectasis is caused by an obstruction, like a mucus plug blocking an airway, the air trapped behind it gets absorbed.
This creates negative pressure in that segment, and it actually pulls the mediastinum towards the collapsed side.
Pulls it towards the problem.
Right.
But if the adellectasis is from compression, say, a massive plural effusion squashing the lung flat, the pressure from the effusion pushes the mediastinum away from the collapsed lung.
So direction of shift tells you a lot about the
fascinating.
Okay.
Segment three, switching gears to obstructive disorders.
Now it's not about structure failing.
It's about flow failing.
Getting air out is the problem.
Exactly.
Asthma and COPD are the big ones here.
Asthma is defined as chronic inflammation, leading to reversible episodes of airway obstruction and hyper responsiveness.
Inflammation is key.
Absolutely.
Often there's an immune component, maybe an exaggerated response to allergens involving specific immune cells like T -helper 2 cells, IgE antibodies, eosinophils, mast cells.
They release all sorts of chemicals that make the airways constrict violently.
What about common triggers?
I know viruses are big, but exercise.
Aspirin.
Yeah.
Viral infections often set off exacerbations, probably by amplifying that inflammatory response.
Exercise -induced asthma is common too.
Theories involve airway cooling and drying, or maybe the rewarming afterwards.
And some people have aspirin or NSAID -sensitive asthma, suggesting a specific problem with how their body metabolizes arachidonic acid, shunting it towards making inflammatory leukotrienes.
Clinically, you hear wheezing.
The patient feels tight -chested.
And expiration takes a long time.
Diagnostically, the key is spirometry, showing a decreased FEV1 -FVC ratio.
Let's quickly define that.
FEV1 is?
Forced expiratory volume in one second.
How much air you can blast out in that first second.
FVC is forced vital capacity, the total amount you can blow out after a deep breath.
So in obstruction, you can't get air out fast.
Exactly.
The FEV1 drops way more than the FVC, so that ratio FEV1 divided by FVC goes down.
That's the hallmark of obstruction.
Okay, moving to chronic obstructive pulmonary disease, COPD.
This one's progressive, mostly smoking, but there's a genetic piece too.
Right.
Alpha -1 antitrypsin deficiency, or ATD.
Alpha -1 antitrypsin is an enzyme that normally protects lung tissue from being broken down by other enzymes called proteases.
If you're efficient in it, genetically, those proteases run wild, especially if you smoke, and destroy lung tissue much faster.
Leading to COPD.
And COPD isn't just one thing, it's usually a mix, but we talk about two classic presentations, emphysema.
Emphysema is really about destruction of the alveolar walls.
The tiny air sacs lose their elasticity and enlarge permanently.
Think loss of elastic recoil.
The lungs become overly compliant, floppy.
Protease is breaking down elastin is key here.
And this leads to the pink puffer description.
Historically, yes.
Because they work so hard to breathe,
using accessory muscles, often pursed lip breathing, they can maintain pretty good oxygenation until late stages, hence pink.
They often have that barrel chest from air trapping and hyperinflation.
And the other side?
Chronic bronchitis.
Chronic bronchitis is actually a clinical diagnosis.
You need a chronic productive cough bringing up sputum for at least three months out of the year, for two years in a row.
So it's about the cough and mucus.
Exactly.
The underlying pathology is inflammation and swelling in the bronchioles, plus the glands that make mucus go into overdrive, they hypertrophy.
So you get narrowed airways clogged with thick mucus.
Which leads to the blue -blooded picture.
Yeah, classically.
They tend to have more problems with low oxygen hypoxia and high CO2 hypercapnia earlier on.
This chronic hypoxemia often leads to pulmonary hypertension and eventually right heart failure, or core pulmonoa, causing peripheral edema, the bloater part.
And the hypoxia contributes to the cyanosis, the blue.
Are those puffer -bloater types still how we should think about it?
They're definitely useful memory aids, linking the main pathology elastin loss versus mucus plugging to a visual.
But in reality, most patients have features of both.
It's usually a spectrum.
Got it.
And the last obstructive disease.
Cystic fibrosis.
Genetic.
Autosomal recessive.
Mutation in the CFTR This gene codes for a protein that works as a chloride channel.
When that channel doesn't work properly, chloride movement is impaired, which messes up sodium and water transport across epithelial surfaces, especially in the airways.
Resulting in thick, sticky, dehydrated mucus.
Just incredibly viscous stuff that clogs up airways, prevents cilia from clearing things, and creates a perfect breeding ground for bacteria.
Chronic infection, particularly with
aeruginosa, is a huge problem.
It affects other organs, too, like the pancreas.
But the lung disease is often the most life -limiting part.
Okay, shifting again.
Segment four.
Chronic interstitial or restrictive lung diseases.
ILDs.
You said these are kind of the opposite of obstructive.
In terms of mechanics, yes.
Obstructive is floppy airways, a hard -to -get air out.
Restrictive means the lung tissue itself becomes stiff, fibrotic, non -compliant.
It's hard to get air in, hard to inflate the lung.
So the problem isn't the airways themselves, but the tissue between the air sacs.
Exactly.
The interstitium, that network of connective tissue, collagen, elastic fibers that supports the alveoli.
When that gets inflamed and scarred, the lungs lose their stretchiness.
This dramatically increases the work of breathing.
What causes this kind of damage?
Lots of things.
Occupational dusts are famous silica -causing silicosis, asbestos -causing
asbestosis.
Particle size is really key for whether they get down deep enough to cause trouble.
Certain drugs can do it, like the chemo agent, Bliomasin.
And then there are immunologic causes.
With a stiff lung that's hard to stretch, how does the breathing pattern change?
They tend to adopt rapid, shallow breathing to Chypnea.
It's less work to take small, fast breaths than deep, slow ones when the lung compliance is low.
They get breathless, often have a dry, nonproductive cough, and can become cyanotic over time.
Lung volumes, like total lung capacity, vital capacity, are reduced.
But the FEV1 -FVC ratio might be normal.
It often is, or even increased, because although the total volume is small, they can still empty it relatively quickly since the airways themselves aren't obstructed.
The volumes are low, not necessarily the flow rate relative to volume.
Sarcoidosis is a big example of an immunologic It is.
It's a systemic disease, meaning it can affect multiple organs, but it has a real preference for the lungs and lymph nodes.
The hallmark is finding non -caseating granulomas, little collections of inflammatory cells in the affected tissues.
We don't fully know the cause, but there seems to be an immune dysregulation, possibly triggered by something environmental and genetically susceptible people.
Okay, final section, segment five.
Pulmonary circulation and acute disorders.
Let's start with a clot on the move.
Pulmonary embolism, PE.
Usually starts as a deep vein thrombosis, a DVT, often in the legs.
Part of that clot breaks off, travels through the bloodstream, and lodges in the pulmonary arteries.
And DVT formation comes back to Virchow's triad.
Yep.
Stasis, blood not moving well, endothelial injury damage to the vein lining, and hypercoagulability, blood that's too prone to clotting.
The case mentioned in the source, Mrs.
French, had risk factors like smoking and oral contraceptive use, both increasing hypercoagulability.
So the clot lodges.
What happens immediately in the lungs?
Massive dead space.
You suddenly have lung regions that are getting air, but zero blood flow because the artery is blocked.
Huge VQ mismatch.
The body responds tachycardia to chipnia trying to compensate.
You might see elevated D -dimer levels, which reflect clot breakdown products.
That blockage and mismatch can lead to high pressure in the lung circulation.
Pulmonary hypertension?
pH.
Right.
pH is just elevated pressure in the pulmonary arteries.
There's primary pH, or PAH, which is rare, often idiopathic or genetic, involving changes in the artery walls themselves.
Think mutations like in the BMPR2 gene.
But secondary pH is more common.
Much more common.
Usually it's a consequence of other diseases.
Chronic lung diseases like COPD or ILDs are major causes.
How does lung disease cause high pulmonary pressure?
Chronic hypoxemia is the main driver.
Unlike blood vessels elsewhere in the body that dilate with low oxygen, pulmonary arteries tend to constrict.
If you have large areas of lung that are poorly oxygenated due to disease, you get widespread pulmonary vasoconstriction, raising the overall pressure.
Left heart failure can also cause it by pressure backing up from the left side.
And if that pressure gets high enough for long enough, the right side of the heart starts to fail.
That's core pulmonary.
Exactly.
The right ventricle isn't built for pressure.
It has to work harder and harder, it hypertrophies, and eventually it fails.
That leads to signs of right heart failure, like neck vein distension, liver congestion, peripheral edema.
Okay, the really big acute one.
Acute Respiratory Distress Syndrome, ARDS.
ARDS is basically the most severe form of acute lung injury, or ALI.
The core problem is widespread damage to the cells lining the pulmonary membrane becomes incredibly leaky.
So fluid just pours into the air sacs.
Fluid, plasma proteins, inflammatory cells, debris, it all floods the alveoli.
This washes out surfactant, the substance that normally keeps the air sacs open, causing them to collapse.
You also get formation of these thick, proteinaceous membranes called hyaline membranes lining the alveoli.
Making the lungs incredibly stiff and wet.
Exactly.
And this leads to the defining feature of ARDS, refractory hypoxemia.
Refractory hypoxemia.
Meaning the patient's oxygen levels remain dangerously low, even when you give them very high concentrations of supplemental oxygen, even 100 % oxygen.
The diffusion barrier is just so damaged, or the alveol are so collapsed or full of fluid that the oxygen simply cannot get across into the blood effectively.
The PF ratio is usually terrible.
Well below 300, often below 200, or even 100.
And ARDS is one cause of the broader condition.
Acute Respiratory Failure,
Correct.
ARF isn't a specific disease, it's more a state defined by numbers.
Arterial PO2 less than 50 mmHg, or PCO2 greater than 50 mmHg, or both.
Two main types.
You can think of it as hypoxemic ARF failure of oxygenation, usually due to VQ mismatch or diffusion problems like in pneumonia or ARDS, or hypercapnic hypoxemic ARF, which is primarily ventilatory failure, failure to move enough air.
Think drug overdose, depressing breathing, or neuromuscular diseases where the breathing muscles are weak.
PCO2 is a good marker here.
And treatment often involves mechanical ventilation, certainly for severe cases.
And a key concept there is using lung protective strategies, typically meaning lower tidal volumes on the ventilator to avoid causing more lung damage from the ventilator itself, something called Violi, ventilator induced lung injury.
So to kind of wrap it all up, every disease we talked about messes with that fundamental O2 exchange.
But you can see how they fall into those categories.
The basic gas imbalances, the inflation failures, the obstructive flow limits, the restrictive stiffness, and then the vascular or acute total failures.
Right.
And knowing that helps connect the dots.
You see someone with that barrel chest.
You think air trapping, loss of recoil, emphysema.
You hear decreased breath sounds and dullness at the lung base.
You think fluid, pleural effusion.
So maybe the final thought for listeners, when you encounter a pulmonary issue, really try to nail down, is this mainly an airflow problem and obstruction?
Or is it a problem with the lung structure and stiffness, a restriction?
And then ask, how does that specific mechanism mess up the VQ ratio?
Because that's usually where the gas exchange failure really starts.
Well said.
It's been great digging into this.
Thanks for joining us for this deep dive.
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
Using this chapter to study? Last Minute Lecture is free and student-run. If it helped, consider supporting the project.
Support LML ♥Related Chapters
- Disorders of Ventilation and Gas ExchangePorth's Essentials of Pathophysiology
- Alterations of Pulmonary FunctionPathophysiology: The Biologic Basis for Disease in Adults and Children
- Alterations of Pulmonary FunctionUnderstanding Pathophysiology
- Care of Patients With Disorders of the Lower Respiratory SystemMedical-Surgical Nursing: Concepts and Practice
- Evaluation and Management of Pulmonary DisordersPrimary Care: Interprofessional Collaborative Practice
- Management of Patients with Chest and Lower Respiratory Tract DisordersBrunner & Suddarth’s Textbook of Medical-Surgical Nursing